Profile data is unavailable for this security.
About the company
Lushang Freda Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacture and sale of pharmaceuticals and cosmetics. In terms of medicine, the Company is committed to the research and development, production and sales of Chinese patent medicines, chemical medicines, and health foods. Its products cover five fields: orthopedics, gynecology, internal medicine, ophthalmology, and pediatrics. The Company's cosmetic products involve aroma therapy, aroma skin care, aroma health care, aroma health care and other fields. In terms of raw materials, derivative products, and additives, the Company is mainly engaged in the production of hyaluronic acid raw materials.
- Revenue in CNY (TTM)4.20bn
- Net income in CNY233.09m
- Incorporated1993
- Employees3.65k
- LocationLushang Freda Pharmaceutical Co LtdNo. 888, Xinluo Avenue, High-tech ZoneJI'NAN 250101ChinaCHN
- Phone+86 53 166699999
- Fax+86 53 166697128
- Websitehttp://www.fruida.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wuhan Keqian Biology Co Ltd | 989.49m | 347.63m | 6.90bn | 923.00 | 19.80 | 1.77 | -- | 6.98 | 0.748 | 0.748 | 2.12 | 8.37 | 0.213 | 1.93 | 3.03 | 1,072,036.00 | 7.47 | 13.29 | 8.81 | 15.49 | 68.82 | 76.49 | 35.09 | 45.71 | 3.65 | -- | 0.0508 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
| Shenzhen Lifotronic Technology Co Ltd | 1.17bn | 347.69m | 6.91bn | 1.48k | 19.85 | 3.62 | -- | 5.88 | 0.8120 | 0.8120 | 2.75 | 4.46 | 0.5409 | 2.32 | 7.90 | 792,478.60 | 15.97 | 13.82 | 19.66 | 16.33 | 65.70 | 61.01 | 29.52 | 26.10 | 3.51 | -- | 0.1004 | 41.51 | 16.55 | 28.78 | 30.66 | 32.27 | -7.91 | -- |
| North China Pharmaceutical Co Ltd | 10.02bn | 17.62m | 7.14bn | 10.16k | 405.06 | 1.34 | -- | 0.7125 | 0.0103 | 0.0103 | 5.84 | 3.11 | 0.4693 | 2.71 | 4.31 | 986,082.90 | 0.3543 | -0.2978 | 0.8122 | -0.7042 | 30.26 | 35.73 | 0.755 | -0.5985 | 0.5425 | 1.43 | 0.6473 | -- | -3.62 | 1.89 | 100.71 | -49.62 | 4.22 | -19.73 |
| Lushang Freda Pharmaceutical Co Ltd | 4.20bn | 233.09m | 7.16bn | 3.65k | 30.70 | 1.76 | -- | 1.71 | 0.2293 | 0.2293 | 4.13 | 4.01 | 0.4446 | 0.8832 | 7.75 | 1,149,606.00 | 3.02 | 0.6992 | 5.84 | 5.12 | 48.44 | 20.23 | 6.79 | 3.45 | 2.67 | -- | 0.1251 | 40.33 | -64.65 | -12.29 | 567.44 | 13.36 | 44.40 | 14.87 |
| Shenzhen Chipscreen Biosciences Co Ltd | 547.79m | 103.01m | 7.31bn | 1.06k | 69.51 | 4.32 | -- | 13.34 | 0.2578 | 0.2578 | 1.33 | 4.15 | 0.1761 | 1.66 | 3.97 | 518,248.70 | 2.14 | 1.32 | 2.61 | 1.54 | 86.99 | 93.29 | 12.17 | 6.97 | 2.99 | -- | 0.4037 | 0.00 | -1.18 | 28.81 | 408.09 | 23.31 | 10.23 | -- |
| Guangxi Wuzhou Zhongheng Group Co Ltd | 3.23bn | 156.14m | 7.32bn | 2.89k | 46.68 | 1.11 | -- | 2.26 | 0.0454 | 0.0454 | 0.9413 | 1.91 | 0.2766 | 1.96 | 3.41 | 1,120,149.00 | 0.9542 | 2.26 | 1.51 | 3.38 | 53.66 | 72.05 | 3.45 | 7.27 | 2.38 | -- | 0.1795 | 45.67 | 14.10 | -1.26 | 6.69 | -32.76 | -4.56 | -30.12 |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.61bn | 109.23m | 7.51bn | 2.21k | 68.76 | 2.04 | -- | 4.67 | 0.2334 | 0.2334 | 3.44 | 7.88 | 0.3034 | 2.01 | 2.86 | 728,818.10 | 1.97 | 1.13 | 2.79 | 1.61 | 67.97 | 67.76 | 6.51 | 3.84 | 1.52 | 6.93 | 0.0284 | 0.00 | 2.24 | 3.78 | -5.78 | 12.43 | -7.11 | -- |
Data as of Jun 26 2024. Currency figures normalised to Lushang Freda Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
5.69%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 13.06m | 1.29% |
| China Life Pension Co., Ltd.as of 30 Sep 2023 | 11.65m | 1.16% |
| HFT Investment Management Co., Ltd.as of 31 Dec 2023 | 8.41m | 0.83% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 4.85m | 0.48% |
| Ping An Annuity Insurance Co. of China, Ltd.as of 30 Sep 2023 | 4.74m | 0.47% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 3.52m | 0.35% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 3.00m | 0.30% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 2.86m | 0.28% |
| Purekind Fund Management Co., Ltd.as of 30 Jun 2023 | 2.78m | 0.28% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 31 Dec 2023 | 2.59m | 0.26% |
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
